Skip to main content
Year archive

Evogene Ltd. — 2025 filings

All 95 regulatory filings released by Evogene Ltd. (EVGN) in 2025, sourced directly from the official regulator.

95 Filings
2025 Period
2025 filings (95)
Filing Released Lang
6-K
Foreign Filer Report
2025-12-30 English
Appointment of Dr. Olga Nissan as its Vice President of Business Development
Board/Management Information
2025-12-30 English
Appointment of Dr. Olga Nissan as its Vice President of Business Development
Report Publication Announcement
2025-12-30 English
6-K
Foreign Filer Report
2025-11-20 English
Reports Third Quarter 2025 Financial Results
Regulatory Filings
2025-11-20 Hebrew (modern)
Reports Third Quarter 2025 Financial Results
Report Publication Announcement
2025-11-20 English
Regulatory Filings 2025
Regulatory Filings
2025-11-20 English
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
Regulatory Filings
2025-11-11 English
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
Report Publication Announcement
2025-11-11 English
POS AM
Regulatory Filings
2025-09-30 English
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
Audit Report / Information H1 2025
2025-09-30 English
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
Report Publication Announcement
2025-09-30 English
6-K
Foreign Filer Report
2025-09-30 English
Results of Operations- Six Months Ended June 30, 2025
Interim / Quarterly Report H1 2025
2025-09-30 English
Results of Operations- Six Months Ended June 30, 2025
Report Publication Announcement
2025-09-30 English
6-K
Foreign Filer Report
2025-09-10 English
Evogene Investor Presentation
Investor Presentation
2025-09-10 English
Evogene Investor Presentation
Report Publication Announcement
2025-09-10 English
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
Report Publication Announcement
2025-08-28 English
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
Regulatory Filings
2025-08-28 English
6-K
Foreign Filer Report
2025-08-19 English
Reports Second Quarter 2025 Financial Results
Earnings Release Q2 2025
2025-08-19 English
Reports Second Quarter 2025 Financial Results
Report Publication Announcement
2025-08-19 English
6-K
Foreign Filer Report
2025-08-18 English
Other Report or Announcement
Declaration of Voting Results & Voting Rights Announcements
2025-08-18 English
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
Regulatory Filings
2025-08-12 English
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
Regulatory Filings
2025-08-12 English
6-K
Foreign Filer Report
2025-08-11 English
Other Report or Announcement
AGM Information
2025-08-11 English
Other Report or Announcement
AGM Information
2025-08-11 English
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
Report Publication Announcement
2025-07-29 English
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
Report Publication Announcement
2025-07-29 English
6-K
Foreign Filer Report
2025-07-17 English
Other Report or Announcement
AGM Information
2025-07-17 English
Other Report or Announcement
Proxy Solicitation & Information Statement
2025-07-17 English
6-K
Foreign Filer Report
2025-07-08 English
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL
Regulatory Filings
2025-07-08 English
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL
Report Publication Announcement
2025-07-08 English
6-K
Foreign Filer Report
2025-06-17 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
AGM Information
2025-06-17 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
AGM Information
2025-06-17 English
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
AGM Information
2025-06-17 English
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
AGM Information
2025-06-17 English
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
AGM Information
2025-06-17 English
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
Regulatory Filings
2025-06-10 English
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
Report Publication Announcement
2025-06-10 English
6-K
Foreign Filer Report
2025-06-05 English
Biomica- Update : Changes in management; Will significantly reduce its internal R&D activity, in line with Evogene’s previously announced new plan
Board/Management Information
2025-06-05 English
Biomica- Update : Changes in management; Will significantly reduce its internal R&D activity, in line with Evogene’s previously announced new plan
Report Publication Announcement
2025-06-05 English
6-K
Foreign Filer Report
2025-05-21 English
Evogene Reports First Quarter 2025 Financial Results
Interim / Quarterly Report Q1 2025
2025-05-21 English
Evogene Reports First Quarter 2025 Financial Results
Report Publication Announcement Q1 2025
2025-05-21 English
will release its financial results for the first quarter of 2025, on May 21, 2025, conference call at 9:00 AM Eastern Time
Earnings Release Q1 2025
2025-05-08 English
will release its financial results for the first quarter of 2025, on May 21, 2025, conference call at 9:00 AM Eastern Time
Report Publication Announcement
2025-05-08 English
6-K
Foreign Filer Report
2025-04-21 English
ICL to Acquire the Activity of Evogene’s Subsidiary , Lavie Bio
Regulatory Filings
2025-04-21 English
ICL to Acquire the Activity of Evogene’s Subsidiary , Lavie Bio
Report Publication Announcement
2025-04-21 English
Regulatory Filings 2025
Regulatory Filings
2025-04-03 English
POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-1
Audit Report / Information FY 2024
2025-03-28 English
POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-1
Capital/Financing Update
2025-03-28 English
FORM S-8-REGISTRATION STATEMENT UNDERTHE SECURITIES ACT OF 1933
Capital/Financing Update
2025-03-28 English
FORM S-8-REGISTRATION STATEMENT UNDERTHE SECURITIES ACT OF 1933
Report Publication Announcement
2025-03-28 English
POS AM
Regulatory Filings
2025-03-28 English
S-8
Registration Form
2025-03-28 English
20F FOR 2024
Annual Report FY 2024
2025-03-27 English
20F FOR 2024
Report Publication Announcement
2025-03-27 English
20-F
Annual Report FY 2024
2025-03-27 English
424B3
Prospectus
2025-03-06 English
Prospectus Supplement
Board/Management Information
2025-03-06 English
Prospectus Supplement
Capital/Financing Update
2025-03-06 English
6-K
Foreign Filer Report
2025-03-06 English
Fourth Quarter and Full Year 2024 Financial Results
Earnings Release Q4 2024
2025-03-06 English
Fourth Quarter and Full Year 2024 Financial Results
Earnings Release FY 2024
2025-03-06 English
6-K
Foreign Filer Report
2025-03-06 English
Changes in the composition of the Board
Board/Management Information
2025-03-06 English
Changes in the composition of the Board
Board/Management Information
2025-03-06 English
Schedules Fourth Quarter 2024 Financial Results Release
Report Publication Announcement
2025-02-20 English
Schedules Fourth Quarter 2024 Financial Results Release
Report Publication Announcement
2025-02-20 English
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease
Regulatory Filings
2025-02-13 English
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease
Report Publication Announcement
2025-02-13 English
424B3
Prospectus
2025-02-12 English
6-K
Foreign Filer Report
2025-02-12 English
Prospectus Supplement No.3 to Prospectus dated September 27, 2024
Declaration of Voting Results & Voting Rights Announcements
2025-02-12 English
Prospectus Supplement No.3 to Prospectus dated September 27, 2024
Report Publication Announcement
2025-02-12 English
Results of Special General Meeting held on February 12, 2025
Regulatory Filings
2025-02-12 English
Results of Special General Meeting held on February 12, 2025
Declaration of Voting Results & Voting Rights Announcements
2025-02-12 English
6K
Foreign Filer Report
2025-02-05 English
Adjournment of Special General Meeting-g will be reconvened on Wednesday, February 12, 2025 at 3:00 p.m. (Israel time)
Regulatory Filings
2025-02-05 English
Adjournment of Special General Meeting-g will be reconvened on Wednesday, February 12, 2025 at 3:00 p.m. (Israel time)
AGM Information
2025-02-05 English
FORM 6-K- Special General Meeting will be reconvened on Wednesday, February 12, 2025 at 3:00 p.m. (Israel time)
AGM Information
2025-02-05 English
FORM 6-K- Special General Meeting will be reconvened on Wednesday, February 12, 2025 at 3:00 p.m. (Israel time)
Regulatory Filings
2025-02-05 English
FORM 6-K- Special General Meeting will be reconvened on Wednesday, February 12, 2025 at 3:00 p.m. (Israel time)
AGM Information
2025-02-05 English
6-K
Foreign Filer Report
2025-01-15 English
Changes in the Management
Board/Management Information
2025-01-15 English
Changes in the Management
Report Publication Announcement
2025-01-15 English